CS logo
small CS logo
c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven

New Haven, Connecticut, United States
Cancer treatment center in New Haven, Connecticut
35 Park St, New Haven, CT 06511

About c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven


"At Yale New Haven Health, we deliver extraordinary, compassionate care by working alongside providers and payers on innovative, cost-effective healthcare delivery models that improve care and value for patients - and enhance the health of our communities."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
3
Total Rows: 1

Clinical Trials at c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven


During the past decade, c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100Started TrialsCompleted Trails201600.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
2013-10-31
2023-12-29
Active, not recruiting
1,401
Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy
No longer available
Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
2016-05-19
2019-05-16
Terminated
998

Rows per page:

1–3 of 3

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 3Pfizer: 3

Created with Highcharts 11.1.0Top CollaboratorsAstellas Pharma Inc: 1Astellas Pharma Inc: 1Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:1Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:1

Clinical Trials Conditions at c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven


According to Clinical.Site data, the most researched conditions in "c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven" are "CD33 Positive Acute Myelogenous Leukemia" (1 trials), "Cancer of the Prostate" (1 trials), "Nonmetastatic Castration-Resistant Prostate Cancer" (1 trials), "Ovarian Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven" in a lesser frequency.

Clinical Trials Intervention Types at c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven


Most popular intervention types in "c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Antibody Drug Conjugate Chemotherapeutic" (1 trials), "Avelumab" (1 trials), "Enzalutamide" (1 trials), "Placebo" (1 trials) and "carboplatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven


The vast majority of trials in "c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven" are 1 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven


Currently, there are NaN active trials in "c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in c/o Thomas Ferencz, RPh, BCOP, Smilow Cancer Hospital at Yale-New Haven, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 2Phase 3: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 1Active, not recruiting: 1No longer available: 1No longer available: 1Terminated: 1Terminated: 1